ELIXIRR INTERNATIONAL
PLC
("Elixirr", the "Company" or
the "Group")
Purchase of Shares by
Employee Benefit Trust
and
Director/PDMR
Shareholding
Elixirr International plc
(AIM:ELIX), an established, global award-winning challenger
consultancy, announces that the Elixirr International plc Employee
Benefit Trust (the "EBT") purchased from certain Directors, PDMRs,
employees and shareholders of the Company (the "Purchase")
1,419,890 ordinary shares in the capital of the Company ("Ordinary
Shares") at a price of 565 pence per Ordinary Share.
The Purchase has been made at the
instruction of Apex Group Fiduciary Services Limited as independent
trustee of the EBT following a recommendation by the Board of the
Company. The decision to make the Purchase is to ensure that the
EBT has sufficient shares to satisfy demand including for
satisfaction of options, equity for new Partners and equity for
those joining the firm through acquisition. Accordingly, the
Purchase will mitigate the need for dilution in the equity of the
Company as it executes on its growth strategy.
Following the Purchase, the EBT's
beneficial holding is 1,782,344 Ordinary Shares representing 3.8
per cent of the issued share capital of the Company.
Participation by certain Directors
and PDMRs in the Purchase are outlined in the table
below:
Director/PDMR
|
Position
|
Ordinary Shares
Sold
|
Share Sale
Price
|
Resultant
Holding
|
% of total voting
rights
|
Gavin Patterson
|
Chair
|
176,991
|
565p
|
439,679
|
0.9%
|
Simon Retter
|
Non-Executive Director
|
88,496
|
565p
|
288,237
|
0.6%
|
Ian Ferguson
|
Executive Director
|
176,991
|
565p
|
2,417,091
|
5.1%
|
Nicholas Willott
|
Finance Director & Company
Secretary
|
20,000
|
565p
|
254,073
|
0.5%
|
Clare Filby
|
Chief Operating Officer
|
35,398
|
565p
|
498,400
|
1.1%
|
Eric Rich
|
Partner
|
79,651
|
565p
|
592,118
|
1.3%
|
Brandon Bichler
|
Partner
|
69,479
|
565p
|
642,712
|
1.4%
|
Dieter Halfar
|
Partner
|
44,248
|
565p
|
316,461
|
0.7%
|
Daniel Garsin
|
Partner
|
24,651
|
565p
|
221,855
|
0.5%
|
For
further information please contact:
Elixirr International plc
Stephen Newton, CEO
Graham Busby, CFO
|
|
|
Public and Investor Relations
contacts:
investor-relations@elixirr.com
Cavendish Capital Markets Ltd (Nominated Adviser & Joint
Broker)
Stephen Keys, Charlie
Beeson (Corporate Finance)
Sunila de Silva (Corporate
Broking)
Investec Bank plc (Joint Broker)
Carlton Nelson, Henry Reast
(Corporate Broking)
|
+44 (0) 20 7220 0500
+44 (0) 20 7597 4000
|
|
|
|
|
|
|
|
|
| |
About Elixirr International plc
Elixirr is an established global
award-winning management consultancy, challenging the larger
consultancies by delivering innovative and bespoke solutions to a
repeat, globally-recognised client base.
Elixirr was founded in 2009, by
Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark
Goodyear, experienced business advisors who identified a market
opportunity to provide bespoke, personal services as a 'challenger'
to the traditional consultancy businesses in the market. Elixirr
guides its clients to overcome challenges such as: future-proofing
against technological disruption; development and roll-out of new
propositions, products and services; incubating new businesses;
navigating a more complex and multinational regulatory environment;
and project management and implementation of major change
programmes.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1.
|
Details of the person discharging
managerial responsibilities / person closely associated
|
a)
|
Name
|
1. Gavin
Patterson
2. Simon
Retter
3. Ian
Ferguson
4. Nicholas
Willott
5. Clare
Filby
6. Eric Rich
7. Brandon
Bichler
8. Dieter
Halfar
9. Daniel
Garsin
|
2.
|
Reason for the
Notification
|
a)
|
Position/status
|
1. Director
2. Director
3. Director
4. PDMR
5. PDMR
6. PDMR
7. PDMR
8. PDMR
9. PDMR
|
b)
|
Initial
notification/Amendment
|
Initial Notification
|
3.
|
Details of the issuer, emission
allowance market participant, auction platform, auctioneer or
auction monitor
|
a)
|
Name
|
Elixirr International plc
|
b)
|
LEI
|
213800MKY7OHMVAKW681
|
4.
|
Details of the transaction(s):
section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date; and (iv) each place where
transactions have been conducted
|
a)
|
Description of the Financial
instrument, type of instrument
|
Ordinary shares of 0.005p each
("Ordinary Shares")
|
Identification code
|
GB00BLPHTX84
|
b)
|
Nature of the transaction
|
Sale of Ordinary Shares
|
c)
|
Price(s) and volume(s)
|
Director/PDMR
|
Price(s)
|
Volume(s)
|
Gavin Patterson
|
565p
|
176,991
|
Simon Retter
|
565p
|
88,496
|
Ian Ferguson
|
565p
|
176,991
|
Nicholas Willott
|
565p
|
20,000
|
Clare Filby
|
565p
|
35,398
|
Eric Rich
|
565p
|
79,651
|
Brandon Bichler
|
565p
|
69,479
|
Dieter Halfar
|
565p
|
44,248
|
Daniel Garsin
|
565p
|
24,651
|
|
d)
|
Aggregated information:
· Aggregated volume
· Price
|
As in 4c) above
|
e)
|
Date of the transaction
|
8 July 2024
|
f)
|
Place of the transaction
|
Off market transaction
|